Latest Leadership News

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

Agrimin Limited has achieved a major milestone with Western Australian state environmental approval for its Mackay Potash Project, alongside government-backed financial support and strategic progress toward project execution.

Aruma Resources advances its exploration portfolio with standout assay results at Fiery Creek and strategic leadership changes, setting the stage for upcoming drilling campaigns.

Lightning Minerals reports a breakthrough spodumene discovery grading up to 4.04% Li2O at its Esperança project in Brazil, alongside multiple lithium drill targets across its Brazilian portfolio, setting the stage for a major drilling campaign in early 2025.

4DMedical reports a remarkable 202% increase in Q2 FY2025 operating revenue, driven by rapid site expansion and key collaborations with leading healthcare providers and the U.S. Department of Defense.

MTM Critical Metals reports solid progress on its US-based Flash Joule Heating demonstration plant, targeting a Q4 2025 start-up in Texas amid favorable regulatory and funding prospects.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

MAC Copper Limited delivered a record quarterly copper production of 11,320 tonnes in Q4 2024, alongside a 12% reduction in cash costs to US$1.66/lb, setting the stage for ambitious growth targets by 2026.

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.

K2 Asset Management has appointed longtime executive Hollie Wight as CEO, signaling a strategic push towards sustained profitability and diversified revenue growth in 2025.

K2 Asset Management Holdings Ltd has won a significant new investment mandate worth approximately A$242 million, expected to increase its revenue by around 15%, reinforcing its strategic growth trajectory.